Biblio Discovery — Demo Discovery Service

21 hasil untuk "Li-Kai Huang"

Menampilkan 1–20 · 0,39 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Clinical trials of new drugs for Alzheimer disease

    Li-Kai Huang; Shu-Ping Chao; Chaur-Jong Hu

    Journal of Biomedical Science, Vol. 27 No. 1 · 2020 · Inggris · DOAJ Scopus

    Abstract Alzheimer disease (AD) accounts for 60–70% of dementia cases. Given the seriousness of the disease and continual increase in patient numbers, developing effective therapies to treat AD has become urgent. Presently, the drugs available for AD treatment, including cholinesterase inhibitors…

    Juga tersedia di: OpenAlex

  2. Artikel Jurnal

    Plasma Phosphorylated-tau181 Is a Predictor of Post-stroke Cognitive Impairment: A Longitudinal Study

    Li-Kai Huang; Shu-Ping Chao; Chaur-Jong Hu dkk.

    Frontiers in Aging Neuroscience, Vol. 14 · 2022 · Inggris · DOAJ Scopus

    IntroductionPost-stroke cognitive impairment (PSCI) cannot be neglected because it drastically influences the daily life of patients and their families. However, there are no studies exploring the association between preclinical blood biomarkers of neurodegeneration including plasma amyloid-β (Aβ)…

  3. Artikel Jurnal

    Suboptimal Baseline Serum Vitamin B12 Is Associated With Cognitive Decline in People With Alzheimer’s Disease Undergoing Cholinesterase Inhibitor Treatment

    Hsiao Shan Cho; Li Kai Huang; Yao Tung Lee dkk.

    Frontiers in Neurology, Vol. 9 · 2018 · Inggris · DOAJ Scopus

    ObjectivesCholinesterase inhibitors (ChEIs) are the mainstream treatment for delaying cognitive decline in Alzheimer’s disease (AD). Low vitamin B12 is associated with cognitive dysfunction, and its supplementation has been applied as the treatment for certain types of reversible dementia. The…

  4. Artikel Jurnal Teks lengkap

    Clinical trials of new drugs for Alzheimer disease: a 2020–2023 update

    Li‐Kai Huang; Yi‐Chun Kuan; Ho-Wei Lin dkk.

    Journal of Biomedical Science · 2023 · Inggris · OpenAlex Scopus

    Alzheimer's disease (AD) is the leading cause of dementia, presenting a significant unmet medical need worldwide. The pathogenesis of AD involves various pathophysiological events, including the accumulation of amyloid and tau, neuro-inflammation, and neuronal injury. Clinical trials focusing on…

    Juga tersedia di: DOAJ

  5. Artikel Jurnal

    Advances in pharmacotherapy for vascular cognitive impairment and vascular dementia: An update of 2025

    Doan‐Khanh Tran; Yi‐Chun Kuan; Li‐Kai Huang dkk.

    Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol. 12 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract Vascular cognitive impairment (VCI), including vascular dementia (VaD), encompasses a spectrum of cognitive deficits resulting from cerebrovascular pathology, ranging from mild impairment to dementia. As the second leading cause of dementia worldwide, VCI remains a major therapeutic…

  6. Artikel Jurnal Teks lengkap

    Heterogeneity of Alzheimer’s disease identified by neuropsychological test profiling

    Truc Tran Thanh Nguyen; Hsun-Hua Lee; Li-Kai Huang dkk.

    PLOS ONE, Vol. 18 No. 10 · 2023 · Inggris · PLOS Scopus

    Alzheimer’s disease (AD) is a highly heterogeneous disorder. Untangling this variability could lead to personalized treatments and improve participant recruitment for clinical trials. We investigated the cognitive subgroups by using a data-driven clustering technique in an AD cohort. People with…

    Juga tersedia di: DOAJ, DOAJ

  7. Artikel Jurnal

    Plasma Amyloid Beta and Tau Levels Are Predictors of Post-stroke Cognitive Impairment: A Longitudinal Study

    Nai-Fang Chi; Shu-Ping Chao; Li-Kai Huang dkk.

    Frontiers in Neurology, Vol. 10 · 2019 · Inggris · DOAJ Scopus

    Objectives: Post-stroke cognitive impairment (PSCI) is a common disease that may occur within 3 months after a stroke or even later. However, the mechanism of PSCI development is unclear. The present study investigated whether the levels of plasma amyloid beta-42 (Aβ42) and tau are associated with…

  8. Artikel Jurnal

    Impaired cerebral autoregulation is associated with poststroke cognitive impairment

    Nai‐Fang Chi; Han‐Hwa Hu; Lung Chan dkk.

    Annals of Clinical and Translational Neurology, Vol. 7 No. 7 · 2020 · Inggris · DOAJ Scopus

    Abstract Objective To investigate whether dynamic cerebral autoregulation (CA) and neuroimaging characteristics are determinants of poststroke cognitive impairment (PSCI). Methods Eighty patients within 7 days of acute ischemic stroke and 35 age‐ and sex‐matched controls were enrolled. In the…

  9. Artikel Jurnal Teks lengkap

    Rifaximin Modifies Gut Microbiota and Attenuates Inflammation in Parkinson’s Disease: Preclinical and Clinical Studies

    Chien-Tai Hong; Lung Chan; Kai-Yun Chen dkk.

    Cells, Vol. 11 No. 21 · 2022 · Inggris · DOAJ Scopus

    Patients with Parkinson’s disease (PD) exhibit distinct gut microbiota, which may promote gut-derived inflammation. Rifaximin is a nonabsorbable antibiotic that can modify gut microbiota. The present study investigated the effect of rifaximin on gut microbiota and inflammation status in PD. The…

  10. Artikel Jurnal

    Cognition, white matter hyperintensities and suicide risk in late-life depression patients: an exploratory study

    Yao-Tung Lee; Li-Kai Huang; Martha Sajatovic dkk.

    BMC Geriatrics, Vol. 25 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Objective Suicide among older adults represents a major public health concern and is closely associated with late-life depression (LLD). White matter hyperintensities (WMHs), frequently observed in the aging population, have been linked to both LLD and cognitive impairment. However, the…

  11. Artikel Jurnal

    Association Between Net Vertebral Artery Flow Volume and Non-AF Stroke: A Retrospective 2-Year Analysis

    Hsun-Hua Lee; Li-Kai Huang; Hwai-Jan Chang dkk.

    Frontiers in Neurology, Vol. 9 · 2019 · Inggris · DOAJ Scopus

    Objectives: Association between net vertebral artery flow volume (NVAFV) and stroke types remains unclear. We hypothesize NVAFV is low in patients with posterior circulation infarction (PCI) and an ideal cut-off value for discriminating PCI from anterior circulation infarction (ACI) and controls…

  12. Artikel Jurnal

    Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects

    Lih-Fen Lue; Ming-Chyi Pai; Ta-Fu Chen dkk.

    Frontiers in Aging Neuroscience, Vol. 11 · 2019 · Inggris · DOAJ Scopus

    Both amyloid plaques and neurofibrillary tangles are pathological hallmarks in the brains of patients with Alzheimer’s disease (AD). However, the constituents of these hallmarks, amyloid beta (Aβ) 40, Aβ42, and total Tau (t-Tau), have been detected in the blood of cognitively normal subjects by…

  13. Artikel Jurnal

    Predictors of caregiver burden in aged caregivers of demented older patients

    Chia-Fen Tsai; Wei-Shen Hwang; Jun-Jun Lee dkk.

    BMC Geriatrics, Vol. 21 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract Background Dementia in the oldest-old is projected to increase exponentially as is the burden of their caregivers who may experience unique challenges and suffering. Thus, we aim to investigate which factors are associated with older caregivers’ burden in caring demented outpatients in a…

  14. Artikel Jurnal

    Assessment of High Risk for Alzheimer’s Disease Using Plasma Biomarkers in Subjects with Normal Cognition in Taiwan: A Preliminary Study

    Chaur-Jong Hu; Ming-Jang Chiu; Ming-Chyi Pai dkk.

    Journal of Alzheimer's Disease Reports, Vol. 5 · 2021 · Inggris · DOAJ Scopus

    Background: In Alzheimer’s disease (AD), cognitive impairment begins 10–15 years later than neurodegeneration in the brain. Plasma biomarkers are promising candidates for assessing neurodegeneration in people with normal cognition. It has been reported that subjects with the concentration of plasma…